1)  calicheamicin
加里刹霉素
2)  CLMs
加里刹霉素
3)  Caledonian
加里东
1.
Determination of the age of gold deposits in southeastern Guizhou: with a discussion of the Caledonian Hunan-Guizhou gold ore belt;
黔东南金矿形成时代的确定兼论湘黔加里东金矿带
2.
Tectonic evolution and sequence stratigraphic framework in South China during Caledonian;
加里东期华南的盆地演化与层序格架
3.
Using seismic, logging, and assaying data, and combined with vitrinite reflectance erosion thickness restoration method and seismic stratigraphy Paleogeomorphology restoration way, we have restored Caledonian paleogeomorphology in the central area of Tarim.
利用地震、测井和分析测试资料,结合镜质体反射率剥蚀厚度恢复法和地震地层学古地貌恢复法,对塔中地区中加里东期古地貌进行了恢复。
4)  Caledonian
加里东期
1.
Caledonian karst palaeogeomorphology and the forming condition of gas pool,southern Ordos Basin;
鄂尔多斯盆地南部加里东期岩溶古地貌与天然气成藏条件分析
2.
Caledonian karstification of Ordovician carbonates in the Tahe oilfield,northern Tarim basin,Northwest China,and its petroleum geological significance;
塔里木盆地北部塔河油田奥陶系加里东期岩溶作用及其油气地质意义
3.
Chronological Study of Caledonian Metamorphic Pegmatite Muscovite Deposits in the Altay Mountains, Northwestern China, and Its Significance;
阿尔泰加里东期变质成因伟晶岩型白云母矿床的成矿年代证据及其意义
5)  Kalimantan
加里曼丹
1.
Cenozoic Au Mineralization and its metallogenic dynamical mechanism in Kalimantan,Southeast Asia;
东南亚加里曼丹新生代金成矿作用及成矿动力学
2.
Evolution of Cenozoic collision orogen of north Kalimantan and its metallogenesis;
东南亚北加里曼丹新生代碰撞造山带演化与成矿
3.
Kalimantan island is located in the S outheastern Asian continental marg inal tectono-magmatic mobile zone in the Western Pacific Oc ean,where the Earth s lithosphere is one of the most compl icated tectonic mobile regions in the earth since the Meso-Cenozoic.
加里曼丹岛位于西太平洋东南亚陆缘构造-岩浆活动带,是自中新生代以来地球岩石圈最复杂的构造活动区之一。
6)  Calgary
卡尔加里
1.
This paper analyzes the master plan and itspractice of Calgary drawn by Thomas H.
Mawson)在近100年前为卡尔加里市(Calgary)所做的城市总体规划及其实施结果的分析,试图总结出北美城市建设快速,且卓有成效的内外成因。
参考词条
补充资料：加里刹霉素
分子式：
CAS号：

性质：由小单孢菌Mi-cromonospora echinosporo、Subsp.Calichesis (LL-E33288，NRRL-15839)产生的一组烯二炔类高效抗肿瘤抗生素。分子量为1200～1400。不溶于水，易溶于有机溶剂。具有很强的抗菌活性及抗瘤作用，其主要成分γ1I对大多数革兰氏阳性细菌及阴性细菌的最小抑菌浓度MIC分别在pg/mL水平及≤1μg/ml，对小鼠移植肿瘤白血病P388及黑素瘤B16的最大活性剂量为5.0与1.25μg/kg，其抗瘤活性比阿霉毒素强4000倍。CLM-γ1I与单克隆抗体的偶联物已进入临床研究阶段，显示出高效的抗肿瘤活性与低毒性。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。